Emory University Hospital - Midtown

A part of Emory Healthcare, the Emory University Hospital Midtown offers a full range of services in midtown Atlanta. The hospital is accredited by the American College of Surgeons Commission on Cancer as a Teaching Hospital Cancer Program. The hospital is also accredited by the American College of Radiology (ACR). The hospital’s mission is to care for patients and their families with concern not only for their illnesses, but also for their mental, emotional and spiritual well-being.

Treatment Sites in Georgia

Clinical Trials in Georgia

A Phase 1 Study of Stereotactic Body Radiotherapy (SBRT) for the Treatment of Multiple Metastases
Cancer Type: Breast Cancer

A Phase 1/2, Open-label, Multi-center Study to Assess the Safety and Tolerability of Durvalumab (Anti-PDL1 Antibody) as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocitic Leukemia
Cancer Type: Hodgkin Lymphoma, Leukemia, Lymphoma, Non-Hodgkin Lymphoma

A Phase 1-2 Multi-Center Study Evaluating the Safety and Efficacy of KTE-C19 in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (r/r ALL) (ZUMA-3)
Cancer Type: Leukemia

A Phase 2 Study of Anti-PD-L1 Antibody (Atezolizumab) in Alveolar Soft Part Sarcoma
Cancer Type: Bone and Soft Tissue (including Sarcoma)

A Phase I Study of VX-970 in Combination with Cisplatin and XRT in Patients with Locally Advanced HPV (-) Head and Neck Squamous Cell Carcinoma (HNSCC; SDC 10060121)
Cancer Type: Head and Neck Cancer, Oral Cancer

A Phase II Trial Assessing the Accuracy of Tumor Bed Biopsies in Predicting Pathologic Response in Patients with Clinical/Radiologic Complete Response after Neoadjuvant Chemotherapy in Order to Explore the Feasibility of Breast Conserving Treatment without Surgery
Cancer Type: Breast Cancer

A Phase IIR/III Trial of Standard of Care Therapy with or without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
Cancer Type: Breast Cancer

A Prospective, Randomized, Double-Blind, Placebo-Controlled Pilot Study of Single-Dose Intraoperative Ketamine for the Prevention of Delirium in Otolaryngeal Cancer Surgery Patients
Cancer Type: Head and Neck Cancer, Oral Cancer

Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Cancer Type: Lung Cancer

Phase I Chemoprevention Study With Green Tea and Erlotinib in Patients With Premalignant Lesions of the Head and Neck
Cancer Type: Head and Neck Cancer
Study Coordinator: Stephanie McMillan - 404-686-1855


Phase Ib Trial of Pembrolizumab and XL888 in Patients with Advanced Gastrointestinal Malignancies
Cancer Type: Colon/Rectal Cancer

Phase II Study of Selective Bladder-Preserving Radiotherapy and Concurrent Radiosensitizing Chemotherapy in Patients With Stage I Bladder Cancer
Cancer Type: Bladder Cancer

Phase III Randomized Study of Standard Adjuvant Endocrine Therapy With Versus Without Chemotherapy in Patients With 1-3 Positive Nodes, Hormone Receptor-Positive, and HER2-Negative Breast Cancer
Cancer Type: Breast Cancer
Study Coordinator: Stephanie McMillan - 404-686-1855


Phase III Randomized Study of Three Different Thoracic Radiotherapy Regimens in Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
Cancer Type: Lung Cancer
Study Coordinator: Jessica Humani - 404-778-5720


Pre-Surgical Trial of Letrozole in Post-Menopausal Patients With Operable Hormone-Sensitive Breast Cancer (Spore)
Cancer Type: Breast Cancer
Study Coordinator: Stephanie McMillan - 404-686-1855


Targeted Fusion Biopsy of the Prostate
Cancer Type: Prostate Cancer

Validation of FACBC as an Early Indicator of Sub-clinical Metastatic Disease among High-Risk Prostate Cancer Patients with Presumed Localized Disease
Cancer Type: Prostate Cancer

WCI1999-11: A Phase II Study of 5-Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Newly Diagnosed or Recurrent Malignant Gliomas
Cancer Type: Brain Cancer
Study Coordinator: Stephanie McMillan - (404) 686-1855